| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.63M | -10,000 | |
| VP | 83.7K | $16.19M | - | |
| VP | 38.3K | $7.42M | - | |
| VP | 34.5K | $6.67M | - | |
| CFO | 33.4K | $6.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2020 | Ring Timothy M53 | Director | Sale+OE | 11,730 | $116.60 | $1,367,718.00 | -36.4% | |
| Apr 27, 2020 | Eglinton Manner Carrie | SVP, Advanced Diagnostics | Sell | 5,000 | $111.02 | $555,075.00 | -9.6% | |
| Apr 27, 2020 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 11,717 | $112.01 | $1,312,432.89 | -4.7% | |
| Mar 16, 2020 | Davis J. E. | EVP, General Diagnostics | Sell | 3,513 | $87.75 | $308,251.21 | -1.7% | |
| Mar 11, 2020 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 2,501 | $104.25 | $260,729.25 | -3.5% | |
| Mar 11, 2020 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 2,175 | $104.25 | $226,743.75 | -5.1% | |
| Mar 10, 2020 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 100 | $112.19 | $11,219.00 | - | |
| Mar 6, 2020 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 230,178 | $112.67 | $25,934,978.32 | -15.8% | |
| Feb 27, 2020 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,011 | $109.68 | $110,883.69 | -1.2% | |
| Feb 27, 2020 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 1,157 | $109.68 | $126,897.90 | -0.8% |